GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArriVent BioPharma Inc (NAS:AVBP) » Definitions » Payments of Debt

AVBP (ArriVent BioPharma) Payments of Debt : $0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is ArriVent BioPharma Payments of Debt?

ArriVent BioPharma's Payments of Debt for the three months ended in Sep. 2024 was $0.00 Mil.

ArriVent BioPharma's Payments of Debt for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.


ArriVent BioPharma Payments of Debt Historical Data

The historical data trend for ArriVent BioPharma's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ArriVent BioPharma Payments of Debt Chart

ArriVent BioPharma Annual Data
Trend Dec21 Dec22 Dec23
Payments of Debt
- - -

ArriVent BioPharma Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

ArriVent BioPharma Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ArriVent BioPharma Payments of Debt Related Terms

Thank you for viewing the detailed overview of ArriVent BioPharma's Payments of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


ArriVent BioPharma Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
18 Campus Boulevard, Suite 100, Newtown Square, Philadelphia, PA, USA, 19073
ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize team's deep drug development experience to maximize the potential of lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.